Crestline Management’s Cogent Biosciences COGT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-369,763
| Closed | -$2.88M | – | 133 |
|
|
2024
Q4 | $2.88M | Hold |
369,763
| – | – | 0.1% | 218 |
|
|
2024
Q3 | $3.99M | Buy |
369,763
+43,693
| +13% | +$472K | 0.21% | 125 |
|
|
2024
Q2 | $2.75M | Buy |
326,070
+11,070
| +4% | +$93.3K | 0.21% | 118 |
|
|
2024
Q1 | $2.12M | Buy |
+315,000
| New | +$2.12M | 0.19% | 130 |
|